Pharmaceutical companies produce record flu vaccine
Pharmaceutical companies produce record flu vaccine
The world's leading pharmaceutical companies are producing record levels of flu vaccine to somehow alleviate the pain in hospitals before winter as the Covid-19 outbreak continues.
 |
| Covid19 |
In the United States alone, the production of influenza vaccines increased 11% over the previous year. Between 2020-2021, 194 to 198 million doses of flu vaccine were produced in the country.
It was determined that the number of non-prescription flu vaccines ordered by pharmacies around the world was twice as compared to the previous year.
Pharmaceutical manufacturer Seqirus will increase vaccine production by 15% next year. It increased the dose from 52 million to 60 million.
The French pharmaceutical giant, Sanofi, increased its production by 20% from 70 million doses to 80 million doses.
Michael Greenberg (Michael Greenberg), Sanofi's North American vaccine production director, told AFP: "We have received many orders from our customers."
Summed up the situation. Last year, between 240,000 and 62,000 deaths occurred in the United States due to the flu.
As the Covid-19 outbreak continues to spread, officials recommend that flu vaccines should be one of the most important public health measures to reduce hospital bed capacity.
In European countries (especially in the United States), campaigns are being developed to make the flu vaccine mandatory.
Comments
Post a Comment